1. Home
  2. XRTX vs WNW Comparison

XRTX vs WNW Comparison

Compare XRTX & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$3.02

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Logo Meiwu Technology Company Limited

WNW

Meiwu Technology Company Limited

HOLD

Current Price

$3.27

Market Cap

3.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRTX
WNW
Founded
2011
2015
Country
Canada
China
Employees
3
N/A
Industry
Pharmaceuticals and Biotechnology
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
3.6M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
XRTX
WNW
Price
$3.02
$3.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.8M
5.7M
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.14
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$0.05
52 Week High
$3.60
$13.52

Technical Indicators

Market Signals
Indicator
XRTX
WNW
Relative Strength Index (RSI) 74.24 52.57
Support Level $0.52 $3.12
Resistance Level N/A $5.43
Average True Range (ATR) 0.37 0.82
MACD 0.06 -0.03
Stochastic Oscillator 64.78 11.19

Price Performance

Historical Comparison
XRTX
WNW

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

Share on Social Networks: